Cellular Agriculture Manufacturing Hub
Cellular Agriculture Manufacturing Hub
批准号:
EP/X038114/1
负责人:
Marianne Ellis
金额:
$1567.53万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
想象一下,能够在世界任何地方,甚至在太空中制造食物,这样每个人,每个地方,都有足够的营养食物吃!这个梦想可以通过细胞农业(Cell Ag)来实现。Cell Ag能够生产通常来自动物的食品,例如来自奶牛的肉和牛奶,或来自单一作物(如油棕榈树)的食品,而不必保持动物或植物数量的增加来养活我们不断增长的全球人口。细胞银,使用生物细胞水平的过程,以创造食物通过'生命的基石' -蛋白质,脂肪和碳水化合物。通过提供这些构建模块,Cell Ag将通过补充传统食品生产来改变食品生产,因此我们不仅可以养活世界,而且我们可以生产食品,以便从一开始就嵌入可持续性和社会责任。为什么我们希望使用细胞抗原而不是动物?让我们以传统肉类中的蛋白质为例。生命周期评估表明,将传统肉类生产与使用Cell Ag的预期效益进行比较时,预计温室气体排放和土地使用将减少高达95%。该分析还估计,与养牛相比,我们可以减少多达50%的用水量。我们可以减少对集约化农业的需求,从而改善动物福利。因此,有了这些好处和迫切需要实现净零制造和保护地球资源。为什么我们没有在我们的家庭或我们所有的食品制造行业中生产细胞银?有几个原因-我们的研究将消除这些阻滞剂的细胞银制造。在英国(和世界各地),有一些优秀的研究正在进行,但很少关注以连贯的方式提供可用和可扩展的制造机械,流程和系统。研究往往是在筒仓和制造价值链的方面集中。有一些基本的研究领域需要交付,以使我们能够实现Cell Ag的潜力,以及将当前的研究成果转化为可用的。通过这个中心,我们将汇集英国的优秀人才,并提供一个连贯和有针对性的研究计划,以确保英国细胞银研究生态系统是世界领先的,并具有制造业的影响。该中心将提供制造业研究,而不是针对特定部门/类型的食品/产品-这将使当地,区域和国际层面的食品生产成为可能。我们的愿景是成为提供材料、制造工艺和技能的世界领导者,以推动世界采用可持续的Cell Ag食品生产。我们将通过成为生命基石的净出口国来实现这一目标。
英文摘要
Imagine being able to manufacture food anywhere in the world, or even in space, so everyone, everywhere, has enough nutritious food to eat! This dream can be achieved through Cellular Agriculture (Cell Ag). Cell Ag enables the production of food products that would normally come from an animal, such as meat and milk from cows, or from monocultures of crops such as oil palm trees, without having to keep increasing animal or plant numbers to feed our growing global population. Cell Ag, uses biological cell-level processes to create food via the 'building blocks of life' - the proteins, fats and carbohydrates. By delivering these building blocks, Cell Ag will transform food production by complementing traditional food production, so not only can we feed the world, but we can manufacture the food so that sustainability and social responsibility is embedded from the outset. Why would we wish to use Cell Ag rather than animals? Let's take the example of the building block, protein, from traditional meat. Life Cycle Assessments have shown that when comparing traditional meat manufacturing against the expected benefits of using Cell Ag, there is a predicted reduction in greenhouse gas emissions, and land use, of up to 95%. The analysis also estimates that we could achieve up to 50% reduction in the use of water, compared to cattle farming. And we could reduce need for intensive farming so improving animal welfare too. So, with these benefits and the urgent need to achieve Net Zero Manufacturing and protect the planets resources.Why do we not have Cell Ag manufacturing in our homes or across all our food manufacturing sectors? There are several reasons - and our research will remove these blockers to Cell Ag manufacturing. Current status of Cell Ag Manufacturing research and outputs in the UK:In the UK (and across the World), there are pockets of excellent research being done, but little that focuses on delivering useable and scalable manufacturing machinery, processes, and systems in a coherent manner. The research tends to be in silos and focussed on aspects of the Manufacturing Value Chain. There are fundamental areas of research that need to be delivered to enable us to realise the Cell Ag potential, as well as transforming current research outputs to be useable. Through this Hub we will bring together the pockets of excellence in the UK, and deliver a coherent and targeted research programme that will ensure the UK Cell Ag research ecosystem is world-leading and has manufacturing impact. Rather than target a particular sector/type of food/product - the Hub will deliver manufacturing research which will enable production of food building blocks at local, regional and international levels. Our vision is to be the world leader in delivering materials, manufacturing processes and skills to escalate the world's adoption of sustainable Cell Ag food production. We will achieve this through becoming the net exporter of the building blocks of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Capillary Bed Bioreactor: Improved Estimation Of Dermal Bioavailability
-
批准号:EP/M506850/1
-
项目类别:Research Grant
-
资助金额:$13.48万
-
财政年份:2014
-
负责人:Marianne Ellis
-
依托单位:
Stem Cell Expansion in a Fluidised Bed Bioreactor for Accelerated Osseointegration of Bone Substitute Material
-
批准号:EP/I015922/1
-
项目类别:Research Grant
-
资助金额:$46.62万
-
财政年份:2011
-
负责人:Marianne Ellis
-
依托单位:
海外基金